Researchers have identified a 14-protein blood signature that may predict lung cancer risk up to five years before diagnosis, ...

As we age, our cells acquire cancer-causing mutations, but mutations alone are rarely enough to start a tumor. An ...

Scientists have identified a blood-based protein signature that can predict lung cancer risk more than five years before ...

OXFORD, England & TORONTO--(BUSINESS WIRE)--Oxford Cancer Analytics (OXcan), the medtech company developing blood tests for early cancer detection using advanced proteomics and AI, today announced it ...

Researchers identified a 14-protein blood signature that may predict lung cancer years early, potentially enabling earlier ...

Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...

Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study Data ...

Lung cancer is the leading cause of cancer deaths worldwide, and early detection is key: there is a 12-fold increase in five-year survivorship between those detected at stage one versus stage four.

Survival outcomes in non-small cell lung cancer: Real-world analysis of immunotherapy era vs pre-immunotherapy era, with insights into treatment settings, racial disparities, and socioeconomic impacts ...